University of Minnesota, School of Public Health, Division of Health Policy and Management, Minneapolis, MN, USA.
Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, USA.
Prim Health Care Res Dev. 2022 Mar 22;23:e18. doi: 10.1017/S1463423622000068.
Mobile Health (mHealth) interventions have received a mix of praise and excitement, as well as caution and even opposition over recent decades. While the rapid adoption of mHealth solutions due to the COVID-19 pandemic has weakened resistance to integrating these digital approaches into practice and generated renewed interest, the increased reliance on mHealth signals a need for optimizing development and implementation. Despite an historically innovation-resistant medical ethos, mHealth is becoming a normalized supplement to clinical practice, highlighting increased demand. Reaching the full potential of mHealth requires new thinking and investment. The current challenge to broaden mHealth adoption and to ensure equity in access may be overcoming a "design purgatory," where innovation fails to connect to practice. We recommend leveraging the opportunity presented by the COVID-19 pandemic to disrupt routine practice and with a new focus on theory-driven replicability of mHealth tools and strategies aimed at medical education and professional organizations.
移动医疗 (mHealth) 干预措施在近几十年来受到了褒贬不一的评价,既有赞扬和兴奋,也有谨慎甚至反对。虽然由于 COVID-19 大流行而迅速采用 mHealth 解决方案削弱了对将这些数字方法整合到实践中的抵制,并重新引起了人们的兴趣,但对 mHealth 的依赖增加表明需要优化其开发和实施。尽管医疗界长期以来一直抵制创新,但 mHealth 正在成为临床实践的常规补充,这凸显了需求的增加。要充分发挥 mHealth 的潜力,需要新的思维和投资。目前扩大 mHealth 采用范围并确保公平获得的挑战可能是克服“设计困境”,即创新无法与实践联系起来。我们建议利用 COVID-19 大流行带来的机会打破常规实践,并将重点放在理论驱动的 mHealth 工具和策略的可重复性上,这些工具和策略旨在针对医学教育和专业组织。